Stock MDNA MEDICENNA THERAPEUTICS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Medicenna Therapeutics Corp.

Equities

MDNA

CA58490H1073

Delayed Toronto S.E.
Other stock markets
 12:57:30 2024-04-24 pm EDT 		5-day change 1st Jan Change
1.85 CAD +19.35% Intraday chart for Medicenna Therapeutics Corp. +6.94% +340.48%
04:48pm Medicenna Therapeutics Up 13% After Flagging Presentations MT
Apr. 16 Transcript : Medicenna Therapeutics Corp. Presents at Bloom Burton & Co. Healthcare Investor Conference 2024, Apr-16-2024 11:00 AM

Evolution of the average Target Price on Medicenna Therapeutics Corp.

Price target over the last 5 years

History of analyst recommendation changes

0f615820a1d11b74f.cK2SeVGttSQmNJQmYytCapcKyWyYJkDctY56smkGfZ0.FdXHEyTI4HViXaxCUWp2HP9T_xWobAuF7fg48DFoGKgnwNERZtXaYm1j5w~cb243bb132f2844c9b9fe80f5c2844ea

Analyst Recommendations on Medicenna Therapeutics Corp.

Oppenheimer Adjusts Medicenna Therapeutics Price Target to $3 From $8, Maintains Outperform Rating MT
HC Wainwright Reiterates Medicenna Therapeutics at Buy With $2.50 Price Target MT
HC Wainwright Adjusts Price Target on Medicenna Therapeutics to $2.50 From $4, Maintains Buy Rating MT
HC Wainwright Adjusts Medicenna Therapeutics' Price Target to $4 From $5, Keeps Buy Rating MT
Oppenheimer Adjusts Medicenna Therapeutics Price Target to $8 From $10, Maintains Outperform Rating MT
HC Wainwright Adjusts Medicenna Therapeutics' Price Target to $5 from $7, Keeps Buy Rating MT
Oppenheimer Adjusts Medicenna Therapeutics Price Target to $10 From $12, Maintains Outperform Rating MT
MEDICENNA THERAPEUTICS : HC Wainwright Adjusts Price Target on Medicenna Therapeutics to $7 From $8, Maintains Buy Rating MT
MEDICENNA THERAPEUTICS : Oppenheimer Starts Medicenna Therapeutics at Outperform With $12 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.55 CAD
Average target price
9 CAD
Spread / Average Target
+480.65%
High Price Target
9 CAD
Spread / Highest target
+480.65%
Low Price Target
9 CAD
Spread / Lowest Target
+480.65%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Medicenna Therapeutics Corp.

Oppenheimer
HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. MDNA Stock
  4. Consensus Medicenna Therapeutics Corp.